托法替尼的安全性与 TNF 抑制剂基本一致

{"title":"托法替尼的安全性与 TNF 抑制剂基本一致","authors":"W. Kathmann","doi":"10.1007/s15002-023-4434-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":237492,"journal":{"name":"Orthopädie & Rheuma","volume":"126 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sicherheitsprofil von Tofacitinib entspricht meist dem von TNF-Hemmern\",\"authors\":\"W. Kathmann\",\"doi\":\"10.1007/s15002-023-4434-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":237492,\"journal\":{\"name\":\"Orthopädie & Rheuma\",\"volume\":\"126 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Orthopädie & Rheuma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s15002-023-4434-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orthopädie & Rheuma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s15002-023-4434-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}